ASA has been shown to downregulate anti-apoptotic protein Bcl-2 expression in human prostate adenocarcinoma LNCaP and human colorectal carcinoma CX-1 cells[26]. This evidence concerns the gene BCL2 and prostate adenocarcinoma.